Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EFEMP2 |
| Upstream (Parents) |
|---|
| (<<) TIMP2 → EFEMP2 |
| Downstream (Children) |
|---|
| EFEMP2 → ACTA2 (>>) |
| EFEMP2 → AKAP12 (>>) |
| EFEMP2 → ANTXR1 (>>) |
| EFEMP2 → ANTXR2 (>>) |
| EFEMP2 → ARSI (>>) |
| EFEMP2 → BMP1 (>>) |
| EFEMP2 → CAV1 (>>) |
| EFEMP2 → CCNB1 (>>) |
| EFEMP2 → CDH11 (>>) |
| EFEMP2 → CREB3L1 (>>) |
| EFEMP2 → CTSF (>>) |
| EFEMP2 → FNDC4 (>>) |
| EFEMP2 → HSPA14 (>>) |
| EFEMP2 → IGFBP4 (>>) |
| EFEMP2 → IGFBP6 (>>) |
| EFEMP2 → IGFBP7 (>>) |
| EFEMP2 → ILK (>>) |
| EFEMP2 → INHBA (>>) |
| EFEMP2 → ISLR (>>) |
| EFEMP2 → ITGA2 (>>) |
| EFEMP2 → ITGA5 (>>) |
| EFEMP2 → ITGB5 (>>) |
| EFEMP2 → LAMB2 (>>) |
| EFEMP2 → LOC399959 (>>) |
| EFEMP2 → LYAR (>>) |
| EFEMP2 → MMP10 (>>) |
| EFEMP2 → MMP2 (>>) |
| EFEMP2 → MN1 (>>) |
| EFEMP2 → MXRA8 (>>) |
| EFEMP2 → MYL9 (>>) |
| EFEMP2 → MYLK (>>) |
| EFEMP2 → NBL1 (>>) |
| EFEMP2 → NNMT (>>) |
| EFEMP2 → PCDH7 (>>) |
| EFEMP2 → PLAT (>>) |
| EFEMP2 → PPP1R15B (>>) |
| EFEMP2 → PROCR (>>) |
| EFEMP2 → PTRF (>>) |
| EFEMP2 → RECK (>>) |
| EFEMP2 → RNASE4 (>>) |
| EFEMP2 → ROR2 (>>) |
| EFEMP2 → SCARF2 (>>) |
| EFEMP2 → SPAG5 (>>) |
| EFEMP2 → SYNPO (>>) |
| EFEMP2 → TCOF1 (>>) |
| EFEMP2 → THBS1 (>>) |
| EFEMP2 → THY1 (>>) |
| EFEMP2 → TIMP3 (>>) |
| EFEMP2 → TPM2 (>>) |
| EFEMP2 → TPM4 (>>) |
| EFEMP2 → TWIST1 (>>) |
| EFEMP2 → ZNF365 (>>) |
